Med Biogene Inc Share Price Toronto S.E.
Equities
MBI
CA58402B1076
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 130K 178K 10.86M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
Net cash position 2022 | 407 556.35 34.02K | Net cash position 2023 | 713 974.64 59.59K | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.96
x | P/E ratio 2023 |
-2.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.35% |
Managers | Title | Age | Since |
---|---|---|---|
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/14/05 |
Ibrahim Ghobrial
DFI | Director of Finance/CFO | - | 05/14/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Toby Weir-Jones
BRD | Director/Board Member | - | 05/14/05 |
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/14/05 |
David Diebolt
BRD | Director/Board Member | - | 05/14/05 |
1st Jan change | Capi. | |
---|---|---|
-44.08% | 7.63B | |
+8.98% | 3.61B | |
+3.94% | 2.36B | |
-24.94% | 1.86B | |
-17.38% | 1.74B | |
+4.89% | 913M | |
+21.75% | 763M | |
-11.57% | 678M | |
-30.82% | 500M |